MRA Announces RFP for Translational Research

16 September 2015 In Science

MRA is pleased to announce a Request for Proposals (RFP) soliciting high-impact translational research from scientists and clinicians around the world. This RFP is for 2015-2016, with awards being announced in the spring of 2016. The RFP calls for ideas that have the potential to lead to near-term clinical application...

Read More


Researcher Q&A: Dr. Neil Ganem

2 September 2015 In Science

In an effort to share more about the work being done in the field of melanoma research, we are beginning a new feature on our blog to showcase some of our funded investigators. Today we’re talking with Neil Ganem, Ph.D., Assistant Professor of Pharmacology and Medicine at Boston University School of...

Read More


Immunotherapy for Melanoma: Where We Are

28 August 2015 In Science

As was reported last week, Former President Jimmy Carter has melanoma that has spread to other organs, and part of his treatment will include an immunotherapy drug. Immunotherapy is a term used to describe treatments that harness the body’s immune system to fight cancer cells.

Read More


What We Can Learn from President Carter’s Melanoma Diagnosis and Treatment

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 21 August 2015 In Treatment

President Jimmy Carter revealed to the world his diagnosis with melanoma with both the grace and bravery that we may all aspire to in the face of such news. His melanoma presentation was a bit unusual and naturally confusing.

Read More


A Conversation with Board Member Jami Gertz

19 August 2015 In Allies & Partnerships

We're featuring an interview with MRA Board Member and actress Jami Gertz on our blog. This was repurposed, with permission, from the blog of our partners at Neiman Marcus. 

Read More


Join Us in Helping Americans Stay Sun Safe This Summer

6 August 2015 In Allies & Partnerships

Today’s blog post is from our partners at Lands End. See how they are joining the fight against melanoma – and how you can get involved. Skin cancer is the most common form of cancer in the United States and Lands’ End wants to keep your skin safe! We are...

Read More


Taking a Closer Look at MRA’s Recent Grant Funding

By Laura Brockway-Lunardi, PhD, MRA Scientific Program Director | 23 July 2015 In Science, Treatment

Melanoma Research Alliance has awarded almost $68 million to 237 PIs at 99 institutions in 14 countries since its founding in 2007

Read More


Sports Authority Helps to Shine Some Light on Melanoma

By Jennifer Engel, MRA Development Manager, Foundations and Campaigns | 9 July 2015 In Allies & Partnerships

In recognition of Melanoma Awareness Month in May, Sports Authority deployed its fifth in-store donation and consumer awareness campaign to raise money for MRA’s research program and to educate customers on ways to reduce their risk of melanoma.

Read More


Ups and Downs for Melanoma. But Staying Focused.

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 25 June 2015 In Science

 This time a week ago I was jubilant. The SU2C-MRA Melanoma Dream Team’s paper describing a precision medicine approach to treating patients had just been published. And in the middle of the week an important article published in the prestigious scientific journal Cell describing the comprehensive genomic landscape of over...

Read More


On the Path to Precision Medicine for Melanoma Patients

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 16 June 2015 In Science

There is no denying the transformative success of new treatments for melanoma ranging from molecularly targeted agents for BRAF-mutant melanoma to immunotherapies like anti-CTLA4 and anti-PD-1 drugs. Indeed, the treatment of BRAF-mutant melanoma is a prime example of Precision Medicine; that is, matching treatments to a patient’s specific disease.

Read More


Login

×